AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
VRA
Vera Bradley, Inc.
There isn't enough reported data to score VRA yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
VRA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
VRA's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
VRA PE Valuation
VRA has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
VRA Forward outlook
There aren't enough analyst estimates for VRA to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over VRA on earnings quality, reporting a profit while its opponent remains loss making.
VRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.37 | +$3.08 |
| Q2 2026 | -$0.69 | +$2.40 |
| Q1 2026 | -$1.72 | +$0.43 |
| Q4 2025 | -$3.43 | -$2.84 |
| Q3 2025 | -$3.45 | -11600% |
| Q2 2025 | -$3.09 | -2307% |
| Q1 2025 | -$2.15 | -960% |
| Q4 2024 | -$0.59 | +$0.01 |
VRA is still losing money, but far less than before: $0.37 per share over the past year, against $3.45 at its worst in mid-2025.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over VRA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over VRA on profitability, with a higher operating margin.
VRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.6M | +1.1% |
| Q2 2026 | $55.7M | +7.8% |
| Q1 2026 | $84.9M | -15% |
| Q4 2025 | $62.3M | -23% |
| Q3 2025 | $70.9M | -36% |
| Q2 2025 | $51.7M | -36% |
| Q1 2025 | $100M | -25% |
| Q4 2024 | $80.6M | -30% |
VRA's revenue has slid since its 2020 peak: $72M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +12 points |
| Q2 2026 | -8.3% | +26 points |
| Q1 2026 | 3.2% | +27 points |
| Q4 2025 | -20% | -6.6 points |
| Q3 2025 | -6.5% | -9.1 points |
| Q2 2025 | -35% | -20 points |
| Q1 2025 | -23% | -21 points |
| Q4 2024 | -13% | -19 points |
VRA's operating margin was 5.8% last quarter, up 12 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
VRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.3M | +$28.4M |
| Q2 2026 | -$5.6M | +$14.2M |
| Q1 2026 | $17.1M | -1.3% |
| Q4 2025 | -$4.5M | +$20.6M |
| Q3 2025 | -$6.1M | -$4.8M |
| Q2 2025 | -$19.8M | -$4.4M |
| Q1 2025 | $17.3M | -33% |
| Q4 2024 | -$25M | -686% |
VRA has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over VRA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
VRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.7% | +1.9M shares |
| 1 year | +7.4% | +2.1M shares |
| 3 years | -3.6% | -1.1M shares |
| 5 years | -13% | -4.5M shares |
| Available history | -12% | -4.1M shares |
VRA has 30M diluted shares, up 7.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $585,000 |
| Q4 2024 | $5.3M |
| Q3 2024 | $9.5M |
| Q2 2024 | $6.3M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -14.1x | Net Cash |
| Q2 2024 | -4.2x | Net Cash |
| Q1 2024 | -4.2x | Net Cash |
| Q2 2022 | -2.1x | Net Cash |
| Q1 2022 | -2.4x | Net Cash |
| Q4 2021 | -2.0x | Net Cash |
| Q3 2021 | -1.8x | Net Cash |
| Q2 2021 | -1.1x | Net Cash |
VRA has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
VRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 82.4 | Overbought |
| Stochastic | 89.3 | Overbought |
VRA's weekly RSI is 82 (overbought) and its Stochastic is 89 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
VRA PE vs Consumer Cyclical Sector
| Metric | VRA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
VRA has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
VRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.91 | 28% above |
| 20 week MA | $4.50 | 68% above |
| 50 week MA | $3.67 | 106% above |
| 100 week MA | $3.08 | 145% above |
| 200 week MA | $4.72 | 60% above |
VRA has climbed back above all five of its weekly moving averages, and it's now 60% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
VRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.6 | $8.10 | -30% |
| 2021 | $8.10 | $8.54 | +5.4% |
| 2022 | $8.54 | $4.13 | -52% |
| 2023 | $4.13 | $7.70 | +86% |
| 2024 | $7.70 | $3.60 | -53% |
| 2025 | $3.60 | $2.28 | -37% |
| 2026 YTD | $2.28 | $7.56 | +232% |
VRA has the edge over AMZN on returns for 2026, with the stronger performance.